Founded in 1989, Suven Life Sciences Limited is a leading biopharmaceutical company headquartered in Hyderabad, India. The company specializes in innovative drug discovery research and development for various therapeutic areas such as central nervous system (CNS), oncology, and cardiovascular diseases. Suven's headquarters, located in Hyderabad, house state-of-the-art research and development facilities.

The company also operates research centers in Nalgonda and Vishakhapatnam, India. These facilities are equipped with cutting-edge technology and employ a highly talented team of scientists and researchers. The main products and services offered by Suven include drug discovery, development, and manufacturing.

The company has a robust pipeline of proprietary clinical-stage molecules and has successfully filed numerous patents globally. Suven also engages in contract research and manufacturing services (CRAMS) for global pharmaceutical majors. In terms of global operations, Suven has established a strong presence in various regions.

The company has subsidiaries in the United States, Canada, and Ireland, which focus on research and development, clinical trials, and marketing activities. Additionally, Suven has formed strategic partnerships and joint ventures with global pharmaceutical companies, facilitating the development and commercialization of its products. With its innovative research and development capabilities, Suven has achieved a prominent position in the global pharmaceutical industry.

The company has a proven track record of creating intellectual property and has received numerous accolades for its scientific achievements. Suven continues to strengthen its market position through strategic alliances and collaborations with leading global pharmaceutical companies. In recent years, Suven has made notable advancements in its drug discovery programs.

The company has expanded its focus on developing novel therapeutics for neurodegenerative disorders and has made significant progress in advancing multiple molecules through various stages of clinical trials. These achievements have further solidified Suven's position as a key player in the biopharmaceutical sector. As of the latest available information, Suven Life Sciences Limited continues to excel in its drug discovery research and development efforts.

The company remains committed to advancing its pipeline of molecules and exploring new therapeutic avenues. Suven's constant drive for innovation and strategic partnerships ensures its continuous growth and success in the global pharmaceutical market